2023 Speakers
2024 Speakers to be coming soon
Jeremy Abbate
Scientific American
Sean Ainsworth
Immusoft
Milad Alucozai, DrPH
BoxOne Ventures
Virginia Amann
ENTENTE Network
Querida Anderson
Editorial Director & Biopharma Expert
Shaun Bagai
RenovoRx
Anna Barry, PhD
Deerfield
Max Bayer
Fierce Biotech
Jonathan Behr, PhD
Dementia Discovery Fund (DDF)
Vincent Beltrani, PhD
Nessan Bermingham, PhD
Khosla Ventures
Jennifer Hawks Bland
NewYorkBIO
Laurence Blumberg, MD
Weill Cornell Medicine
Jenna Brager, PhD
MyMD Pharmaceuticals
Derek Brand
Columbia University
Rick Bright, PhD
Pandemic Prevention & Response
Steve Brozak, DMH
WBB Securities
Hilary Brueck
Insider
Jay Campbell
Cancer Research Institute (CRI)
Gloria Caulfield
Tavistock Development Company
Nate Chang
Playground Global
Timothy Cooke
Orlando VA Healthcare System (VAHCS)
Steven Damon
Micron Biomedical
Olga Danilchanka, PhD
MRL Ventures Fund, Merck
Roy de Souza
BreakBio
JoAnn Difede, PhD
Weill Cornell Medicine
Michael Dowling
Northwell Health
David Ewing Duncan
Journalist, Author, Researcher
Jakob Dupont, MD
Sofinnova Investments
Esther Dyson
Wellville
Mark Edwards
ViewMind
Eric Elenko, PhD
PureTech
Ryan Field, PhD
Kernel
Seth Flaum
Wilson Sonsini
Michael Goldberg, PhD
SURGE Therapeutics
Walter Greenleaf, PhD
mediaX – Stanford University
Kimberly Ha
KKH Advisors
Kurt Haggstrom
Synchron
Nouhad Husseini
Regeneron Pharmaceuticals
Zegbeh Jallah, PhD
Capital One
Anthony Johnson
Kodikaz Therapeutic Solutions
Marc Jones
Altoida
Elizabeth Kavaler, MD
Total Urology Care of New York
Daniella Kranjac
Dynamk Capital
Seema Kumar
Cure
Wyatt McDonnell, PhD
Infinimmune
Georgia Mitsi, PhD
Emerald BioVentures
Mani Mohindru, PhD
Novasenta
Caroline Montojo, PhD
Dana Foundation
Kwame Okrah, PhD
Sanavia Oncology
Daniel Oliver
Rejuvenate Bio
Tim Opler, PhD
Stifel
Art Pappas
Pappas Capital
Timothy Peters-Strickland, MD
PPD Biotech Solutions, part of Thermo Fisher Scientific
Andy Plump, MD, PhD
Takeda Pharmaceutical Company Ltd
Eric Rackow, MD
eFamilyCare
Angela Radcliffe
How Mighty We Ventures
Beth Rogozinski
Oncoustics
Susan Rosenthal
New York City Economic Development Corporation
Sony Salzman
ABC News
George Santo
JPMorgan
Sal Saraceno
Capital One
Thomas Seoh
Kitalys Institute
Kayj Shannon
Alix Ventures
Nick Shipley
BIO
Ali Siam
Rubedo Life Sciences
Christine Silverstein
Excision BioTherapeutics
Greg Simon
Former Director, White House Cancer Moonshot
Ajit Singh, PhD
Artiman Ventures
Sourav Sinha
Longevity Vision Fund
Brad Sitko
XOMA
Brent Vaughan
Cognito Therapeutics
John Wagner, MD, PhD
Koneksa
Kate Walsh
HSBC Innovation Banking
Robert Williamson
Triumvira Immunologics
Elizabeth Wood, PhD
JURA Bio
Lei Lei Wu
Endpoints News
Hanadie Yousef, PhD
Juvena Therapeutics